Epigenetic mechanisms have been proposed to play crucial roles in mammalian development, but their precise functions are only partially understood. To investigate epigenetic regulation of embryonic development, we differentiated human embryonic stem cells into mesendoderm, neural progenitor cells, trophoblast-like cells, and mesenchymal stem cells and systematically characterized DNA methylation, chromatin modifications, and the transcriptome in each lineage. We found that promoters that are active in early developmental stages tend to be CG rich and mainly engage H3K27me3 upon silencing in nonexpressing lineages. By contrast, promoters for genes expressed preferentially at later stages are often CG poor and primarily employ DNA methylation upon repression. Interestingly, the early developmental regulatory genes are often located in large genomic domains that are generally devoid of DNA methylation in most lineages, which we termed DNA methylation valleys (DMVs). Our results suggest that distinct epigenetic mechanisms regulate early and late stages of ES cell differentiation.
SUMMARY
Epigenetic mechanisms have been proposed to play crucial roles in mammalian development, but their precise functions are only partially understood. To investigate epigenetic regulation of embryonic development, we differentiated human embryonic stem cells into mesendoderm, neural progenitor cells, trophoblast-like cells, and mesenchymal stem cells and systematically characterized DNA methylation, chromatin modifications, and the transcriptome in each lineage. We found that promoters that are active in early developmental stages tend to be CG rich and mainly engage H3K27me3 upon silencing in nonexpressing lineages. By contrast, promoters for genes expressed preferentially at later stages are often CG poor and primarily employ DNA methylation upon repression. Interestingly, the early developmental regulatory genes are often located in large genomic domains that are generally devoid of DNA methylation in most lineages, which we termed DNA methylation valleys (DMVs). Our results suggest that distinct epigenetic mechanisms regulate early and late stages of ES cell differentiation.
INTRODUCTION
Embryonic development is a complex process that remains to be understood despite knowledge of the complete genome sequences of many species and rapid advances in genomic technologies. A fundamental question is how the unique gene expression pattern in each cell type is established and maintained during embryogenesis. It is well accepted that the gene expression program encoded in the genome is executed by transcription factors that bind to cis-regulatory sequences and modulate gene expression in response to environmental cues (Young, 2011) . Growing evidence now shows that maintenance of such cellular memory depends on epigenetic marks such as DNA methylation and chromatin modifications (Bird, 2002; Kouzarides, 2007) .
DNA methylation at promoters has been shown to silence gene expression and thus has been proposed to be necessary for lineage-specific expression of developmental regulatory genes, genomic imprinting, and X chromosome inactivation (Bird, 2002) . Indeed, the DNA methyltransferases DNMT1 or DNMT3a/3b double-knockout mice exhibit severe defects in embryogenesis and die before midgestation, supporting an essential role for DNA methylation in embryonic development (Li et al., 1992; Okano et al., 1999) . On the other hand, mouse embryonic stem cells (mESCs) lacking all three DNMTs can survive and self-renew and can even begin to differentiate to some germ layers (Jackson et al., 2004; Tsumura et al., 2006) , raising the possibility that DNA methylation is dispensable for at least initial lineage specification in early embryos. Thus, the role of DNA methylation in animal development needs to be more precisely defined. Like DNA methylation, chromatin modifications have also been shown to play a key role in animal development. Enzymes responsible for methylation of histone H3 at lysine 4, 9, and 27, in particular, are essential for embryogenesis (Kouzarides, 2007; Vastenhouw and Schier, 2012) . Additionally, depletion of the histone acetyltransferase p300 or CBP also leads to early embryonic lethality (Yao et al., 1998) . Although both DNA methylation and chromatin modifications are critical for mammalian development, the exact role of each epigenetic mark in the maintenance of lineage-specific gene expression patterns remains to be defined.
In humans, studying the epigenetic mechanisms regulating early embryonic development often requires access to embryonic cell types that are currently difficult or impractical to obtain. Human embryonic stem cells (hESCs) (Thomson et al., 1998) can be differentiated into a variety of precursor cell types, providing an in vitro model system for studying early human developmental decisions. We have established protocols for differentiation of hESCs to various cell states, including trophoblast-like cells (TBL) (Xu et al., 2002) , mesendoderm (ME) (Yu et al., 2011) , neural progenitor cells (NPCs) (Chambers et al., 2009; Chen et al., 2011) , and mesenchymal stem cells (MSCs) (Vodyanik et al., 2010) . The first three states represent developmental events that mirror critical developmental decisions in the embryo (the decision to become embryonic or extraembryonic, the decision to become mesendoderm or ectoderm, and the decision to become surface ectoderm or neuroectoderm, respectively). MSCs are fibroblastoid cells that are capable of expansion and multilineage differentiation to bone, cartilage, adipose, muscle, and connective tissues (Vodyanik et al., 2010) . The specific hESC derivatives chosen thus reflect key lineages in the human embryo and also represent those lineages that currently can be produced in sufficient quantity and purity for epigenomic studies. These lineages will complement other cells from more mature sources, many of which have had their epigenomes well characterized (Hawkins et al., 2010; Lister et al., 2009; Zhu et al., 2013) . Importantly, epigenomic analysis of these cell types allows for investigation of chromatin and transcriptional changes that drive the initial developmental fate decisions.
Here, we used high-throughput approaches to examine the differentiation of hESCs into four cell types by generating in-depth maps of transcriptomes, a large panel of histone modifications, and base-resolution maps of DNA methylation for each cell type. Our study provided a full view of the dynamic epigenomic changes accompanying cellular differentiation and lineage specification. As outlined below, an integrative analysis of these data sets provided us with substantial insights into the role of DNA methylation and chromatin modifications in animal development.
RESULTS

Generation of Comprehensive Epigenome Reference Maps for hESCs and Four hESC-Derived Lineages
We differentiated the hESC line H1 to ME, TBL, NPCs, and MSCs ( Figure 1A ) (Extended Experimental Procedures). ME, TBL, and NPC differentiation occurred quickly (2 days, 5 days, and 7 days, respectively) compared to that of MSC (19-22 days). The expression of various marker genes in these cells was confirmed using immunofluorescence and fluorescence-activated cell sorting (FACS), and the purity of each cell population ranged from 93% to 99% (Figures S1A-S1C available online). ME, NPCs, and MSCs possess further differentiation potentials as shown in Figures S1D and S1E (for ME and NPCs) and our previous study (for MSCs) (Vodyanik et al., 2010) . On the other hand, the nature of TBL is still currently under debate (Bernardo et al., 2011; Xu et al., 2002) . As a control for terminally differentiated cells, we also cultured and analyzed IMR90, a primary human fetal lung fibroblast cell line. For each cell type, we mapped DNA methylation at base resolution using MethylC-seq (Lister et al., 2009 ) (20-353 total genome coverage or 10-17.53 coverage per strand). We also mapped the genomic locations of 13-24 chromatin modifications by chromatin immunoprecipitation sequencing (ChIP-seq). Additionally, we performed paired-end (100 bp 3 2) RNA-seq experiments, generating more than 150 million uniquely mapped reads for every cell type ( Figures 1A and 1B) . At least two biological replicates were carried out for each analysis, and the data were publicly released as part of the NIH Roadmap Epigenome Project (http://www.epigenomebrowser.org/). Selected data are also available at http://epigenome.ucsd.edu/differentiation.
Identification of Differentially Expressed Genes in hESC-Derived Cells
We first asked how the genome is differentially transcribed when hESCs are differentiated into each cell type. To do so, we examined the expression of 19,056 RefSeq coding genes (33,797 isoforms), among which 76.6% (14,595) were expressed in at least one cell type ( Figure S2A ). Using an entropy-based method (Barrera et al., 2008; Schug et al., 2005) (Figure S2B ), we identified 2,408 genes that showed cell-type-specific expression (Figures 2A and S2A) . For convenience, we use ''lineage-restricted genes'' to reflect both H1-specific and differentiated cell-specific genes. As expected, known lineage markers were highly expressed in the corresponding cell types (Figure 2A ). It is worth noting that, in line with a previous report (Yu et al., 2011) , the ME cells also express high levels of the hESC regulators NANOG, POU5F1, and a reduced but significant level of SOX2. We then investigated a cohort of long noncoding RNA (lncRNA) genes and detected significant levels of transcripts for 2,175 known and 281 unannotated lncRNA genes in at least one cell type (Figures 2A and S2A ). Using the same entropy-based approach, we found 930 lncRNA genes defined as lineage restricted ( Figure S2C ), which constitute 37.9% of total expressed lncRNA genes. By contrast, only 16.5% of expressed coding genes are characterized as lineage restricted (Figure S2D) . The above analysis defined a large number of coding and noncoding genes that are differentially expressed in H1 and its derived cells. The lists of all lineage-restricted genes are included in Table S1 .
Intriguingly, the promoters of several lncRNA genes highly expressed in H1 overlap with the long terminal repeat (LTR)-containing retrotransposons ( Figure 2B ). This appears to be a general phenomenon as we observed that significant percentages of transcription start sites (TSSs) of lncRNA genes directly fall into LTRs ( Figure 2C ). The percentages are notably higher for H1-and ME-enriched lncRNA genes (30% and 31%, respectively), which are in contrast to those of coding genes (<2%). By quantifying the transcription levels of all major classes of mappable repetitive elements, we found that the ERV1 (class I endogenous retrovirus) elements are preferentially expressed in H1 and ME, but not in other cell types ( Figure 2D, Figure S1 .
sively at the ERV1 subfamily HERV-H and its flanking LTR elements LTR7 (Figure 2D , bottom). Together, HERV-H and LTR7 account for more than 43% of LTRs that are present at H1-and ME-specific lncRNA gene promoters. A gene ontology analysis of coding genes near H1-specific HERV-H/LTR7 sites revealed an enrichment of POU5F1-targeted genes (p value = 4 3 10 À15 ), which is consistent with a previous study showing that NANOG and POU5F1 preferentially bind to repetitive elements (Kunarso et al., 2010) . We did not find significant enrichment of LTR subclasses for other lineage-restricted lncRNA genes. Repetitive elements are known to be regulated by DNA methylation and H3K9me3 in ESCs (Leung and Lorincz, 2012) . We do not find significant enrichment of H3K9me3 around most HERV-H elements (data not shown). By contrast, a subset of the H1-specific HERV-H elements (n = 70) show hypomethylation in H1 and ME but gain DNA methylation in other H1-derived cells (Figures 2B and 2E) . Notably, the overall low level of DNA methylation in IMR90 reflects its globally hypomethylated genome, likely due to the presence of partially methylated domains (PMDs) (Figures S2E and S2F) (Lister et al., 2009) . Additionally, by examining published methylomes (Lister et al., 2011) , we found that DNA methylation at these regions was depleted upon reprogramming of IMR90 or foreskin fibroblasts to iPSCs and was then reestablished when the fibroblast-derived iPSCs were differentiated to trophoblast-like lineage ( Figure 2B ). Together, these data suggest that many noncoding RNA genes may be transcriptionally regulated by endogenous retroviral sequences. Of particular interest, the expression of HERV-H/LTR7 is closely correlated with the state of pluripotency and may be regulated by DNA methylation.
Dynamic DNA Methylation and Chromatin Modifications at Promoters of Lineage-Restricted Transcripts
Previous studies have shown that the promoters for somatic-tissue-specific genes are often CG poor and lack CpG islands (CGIs), in contrast to those for housekeeping genes, which are CG rich and predominantly contain CGIs (Barrera et al., 2008; Schug et al., 2005) . Therefore, we asked whether early lineage-restricted promoters also demonstrate similar features as tissue-specific promoters. We first identified promoters for each lineage-restricted gene and excluded those with ambiguous active promoters (Extended Experimental Procedures). Next, we divided the promoters into three groups based on CG density (high, medium, and low) ( Figure S3A) . Surprisingly, genes preferentially expressed in early embryonic lineages H1, ME, and NPC tend to be CG rich and contain CGIs ( Figure 3A ). The percentages of CGI-containing promoters decreased for genes enriched in MSCs and IMR90, which are at relatively late development stages. By contrast, a much lower percentage of promoters (23%) contain CGIs for somatic-tissue-specific genes identified from 18 human tissues (Zhu et al., 2008 ) ( Figure 3A ). We further verified this using an independent set of somatic-tissue-specific genes (35%) (Chang et al., 2011) . These data suggest that the promoters used for lineage specification in early stages of cell differentiation have distinct sequence features compared to those in more mature cell types. DNA methylation machinery has been shown to be a mechanism of gene silencing during cell differentiation (Bird, 2002) . In addition, the Polycomb protein complex, which deposits H3K27me3 at target genes, can also repress developmental genes Lee et al., 2006) . We set to determine which promoters are subject to regulation by DNA methylation, H3K27me3, or both. A detailed analysis showed that promoters with high CG density tend to be enriched for H3K27me3, whereas those with low CG density are preferentially marked by DNA methylation (Figures 3B and 3C ). This is exemplified by the promoters of the ME marker T (high CG, with a CGI) and the hESC marker POU5F1 (medium CG, no CGIs) (Figures 3D and 3E) . Notably, whereas both H3K27me3 and DNA methylation are largely anticorrelated with gene expression, high CG promoters are often marked by reduced but significant enrichment of H3K27me3 even when they are active (Figures 3B and 3D) . It has been shown that the PRC2 complex can be directly recruited by CG-rich sequences (Mendenhall et al., 2010) . Consistent with this model, our data indicate that the sequence of a promoter could contribute to the epigenetic mechanisms that affect its regulation.
Notably, the majority of developmental regulatory genes, including SOX2, NODAL, EOMES, T, SOX17, and SOX1, belong to the high CG group and are marked by H3K27me3 ( Figure 3B ). DNA methylation, on the other hand, marks a relatively small number of lineage-restricted genes, including NANOG and POU5F1. A gene ontology analysis also showed that lineagerestricted genes with high CG promoters are enriched for developmental genes, embryonic morphogenesis, and pattern specification, whereas those with low CG promoters contain genes that function in plasma membrane, disulfite bond, and protein kinase cascade. As controls, somatic-tissue-specific promoters are largely CG poor, often showing high level of DNA methylation; housekeeping gene promoters are predominantly CG rich, showing neither DNA methylation nor H3K27me3 in these cells ( Figure S3B ). Interestingly, some CGpoor promoters are also marked by low levels of H3K27me3. These promoters are largely observed in the expanded H3K27me3 domains ( Figures 3B and 3F , black arrow), a broad pattern of enrichment for H3K27me3 (Hawkins et al., 2010; Zhu et al., 2013 ) that frequently occurs in MSCs and IMR90, but less so in H1 and other H1-derived cells ( Figure S3C and data not shown). These observations suggest that the expansion of H3K27me3 may be a mechanism to lock low CG promoters in a repressed state in later development stages. Consistently, H3K27me3 shows similar negative correlations with gene expression in all three classes ( Figure 3G ). By contrast, DNA methylation shows the strongest negative correlation with gene expression for low CG genes (see Figure S3D for the analysis of additional histone modifications). Together, our data suggest that, although H3K27me3 may play a widespread role in regulating key factors of cellular differentiation, DNA methylation is involved in modulation of many somatic-tissue-specific genes and a limited number of-albeit critical-developmental regulators.
Dynamic DNA Methylation and Chromatin Modifications at Enhancers Reflect Lineage-Restricted Gene Expression
Enhancers are distal regulatory elements that mediate tissue and developmental-stage-specific gene expression (Ong and Corces, 2011) . To examine the potential role of DNA methylation and chromatin modifications at enhancers, we first identified a total of 103,982 putative enhancer sites in the six cell types (Table S2 ) by using an enhancer prediction method described recently (Rajagopal et al., 2013 ) (Extended Experimental Procedures). By examining the level of H3K27ac, a marker for active enhancers (Creyghton et al., 2010; Rada-Iglesias et al., 2011) , we classified 32,423 enhancers as lineage restricted using the entropy-based analysis ( Figure S4A , Table S2 , and Extended Experimental Procedures). We validated these enhancers using several approaches by showing that they extensively overlap with the binding sites of transcriptional regulators or DNase I hypersensitive sites (J.A. Stamatoyannopoulos, personal communication) ( Figure S4B) ; they show evolutional conservation in sequences ( Figure S4C) ; they are enriched for motifs of transcription factors known to function in each lineage (Figure S4D and Table S3 ); and their neighboring genes demonstrate functional enrichment that is related to their lineage identities ( Figure S4E ). Finally, we constructed eight GFP reporters containing various lineage-specific enhancers and injected them in zebrafish embryos. A high percentage of these enhancers (50%) demonstrated activity in vivo in specific lineages regardless of their positions relative to the reporter gene ( Figure S4F ). Together, these data suggest that we have identified a set of lineage-restricted enhancers of high quality in hESCs and hESCderived cells.
We subsequently examined the dynamic epigenetic modifications at lineage-restricted enhancers. As these modifications at intragenic enhancers can be confounded by the activity of their hosting genes, we focused on intergenic lineage-restricted enhancers (n = 6,819) for this analysis (enhancers present in PMDs in IMR90 were also excluded). Most enhancers are CG poor (94%) and appear to be depleted of H3K27me3 ( Figure 4A ). However, weak enrichment of H3K27me3 is observed at a subset of enhancers in MSCs and IMR90. These enhancers are largely active in H1, ME, NPCs, and TBL, but not in MSCs and IMR90, as indicated by the levels of H3K27ac. A closer examination revealed that these enhancers are preferentially present in the H3K27me3 domains specific to MSCs and IMR90 (see Figure 4B for an example). In IMR90 and MSCs, repressed enhancers are marked by a higher level of H3K27me3 compared to active enhancers ( Figure 4C ). By contrast, this is less evident for enhancers in H1 and other H1-derived cells. These results are consistent with the mode that the H3K27me3 domains that arise in differentiated cells may function to repress enhancers that are active in other lineages (Hawkins et al., 2010; Zhu et al., 2013) .
Our data also showed that the presence of DNA methylation negatively correlates with the activity of enhancers ( Figure 4C ). Interestingly, although some H1-specific enhancers acquire DNA methylation in MSCs and IMR90, this is less evident in ME, NPCs, and TBL ( Figures 4A and 4D ). These data are in line with a recent study showing that inactive regulatory elements tend to progressively gain DNA methylation over time during Scatterplots showing the levels of DNA methylation in each cell type at H1-specific enhancers (blue) and differentiated cell-specific enhancers (green). In the last two panels, colon-and blood-specific enhancer information (green dots) is not available in Berman et al. (2012) and Li et al. (2010) . (E) Box plots showing the distribution of Pearson correlation coefficients between the levels of various histone modifications or DNA methylation at enhancers and the expression level of their potential target genes. See also Figure S4 . cell differentiation (Bock et al., 2012) . By contrast, differentiated cell-specific enhancers appear highly methylated in lineages where they are inactive. We do not observe significant differences between H1-specific and differentiated cell-specific enhancers in their proximity to the nearest TSSs (data not shown). Notably, some H1-specific enhancers remain hypomethylated even in MSCs, IMR90, and two human tissues: peripheral blood mononuclear cells and the colon (mucosa) (Berman et al., 2012) ( Figure 4D ). The functions of these hypomethylated enhancers remain to be explored. Together, these data indicate that H3K27me3 is preferentially enriched at a subset of enhancers in a later stage of cellular differentiation. By contrast, DNA methylation is widely present at enhancers of all stages and negatively correlates with their activity.
We further examined whether the presence of DNA methylation or H3K27me3 may correlate with the expression of genes that are potentially regulated by enhancers. To do so, we identified candidate target genes of lineage-restricted enhancers using correlative analyses (Ernst et al., 2011) (Table S4 and Extended Experimental Procedures). At enhancers, histone acetylation is generally positively correlated with the expression of enhancer-targeted genes ( Figures 4E and S4G ). H3K27me3 and DNA methylation, by contrast, show an inverse relationship with gene expression of their potential target genes. The analysis results for expanded histone marks are included in Figure S4G .
Identification of DNA Methylation Valleys
Previously, low methylation regions (LMRs) and unmethylated regions (UMRs) have been suggested to function as cis elements (Stadler et al., 2011) . Applying the same approach as Stadler et al. (2011) , we defined 5,323 to 31,158 UMRs and 32,744 to 74,541 LMRs in H1 and its derived lineages (Table S5) . Indeed, more than 85% of UMRs and 42% of LMRs are present in either enhancers or promoters. Surprisingly, although LMR and UMRs are generally short (median lengths 252 bp and 532 bp, respectively), a number of loci show a much wider depletion of DNA methylation. Interestingly, they often appear near genes for transcription factors and developmental regulators. For example, a 9.3 kb hypomethylated region is observed at GSC, a transcription factor specifically expressed in ME ( Figure 5A ). This unmethylated region covers the entire gene body and regions beyond, which is in contrast to a typical UMR (CLMN, Figure 5A ). We sought to investigate whether such broad DNA methylation depletion around developmental genes is a general phenomenon. By examining all continuous hypomethylated regions in H1 and the H1-derived cells ( Figures S5A and 5B) , we identified those that are at least 5 kb long, which constitute less than 3.2% of all hypomethylated regions in any cell type. We named these regions DNA methylation valleys (DMVs). IMR90 was excluded from this part of our study due to the presence of PMDs in these cells (Lister et al., 2009) (Figure S2F ), which would confound the analyses. Genome wide, we identified 639, 1,004, 933, 944, and 962 DMVs in H1, ME, NPC, TBL, and MSC, respectively, among which 461 are shared by all cell types ( Figure 5C ; see Table S6 for the full lists). Together, these regions occupy 1,220 distinct genomic loci. Strikingly, nearly every DMV (99.7%) contains at least one known (89.9%) or putative promoter (9.8%, as indicated by the presence of H3K4me3). The majority of DMVs (93.8%, n = 1,144) contain at least one CGI. Interestingly, whereas 51.8% DMVs contain one or less CGI, 23.7% (289) DMVs contain at least three CGIs ( Figure S5B ). These DMVs range in size from 5 kb to 68 kb and are much larger than the CGIs in these regions ( Figure 5D ). About 67% of DMVs contain at least half non-CGI sequences even when we used a much larger CGI list (n = 63,956) (Irizarry et al., 2009 ) instead of the UCSC CGI list (n = 27,639). We then asked whether DMVs are conserved across species. Indeed, DMVs show high level of sequence conservation ( Figure 5E ). Additionally, we searched for DMVs in mice using a brain methylome that we recently obtained (Xie et al., 2012) . Strikingly, a large number of genes with DMVs in humans (638, or 59%, p value < 1 3 10 À100 ) are also present in DMVs in mice ( Figure 5F ). Finally, many DMVs (>40%) found in H1 and its derivatives were also observed to be such in adult tissues (Berman et al., 2012; Li et al., 2010) (Figure S5C ), suggesting that DMVs are not artifacts of cell culture. The different numbers of DMVs in various cell types may be in part attributed to variations in sequencing depth and methylome coverage of promoters ( Figure S5D ). Intriguingly, DMVs contain a unique set of genes. In total, 1,086 coding genes are found in the 1,220 DMVs (Table S7 ). The majority (91.5%) of their promoters are CG rich ( Figure S5E ). No significant differences in gene sizes are found for DMV genes with CGIs compared to non-DMV genes with CGIs (data not shown). Strikingly, a gene ontology analysis showed that these genes are strongly enriched for functional groups in transcription factors, homeobox family, developmental protein, and embryonic morphogenesis ( Figure 5G ). In fact, 38.4% (415) of coding genes in DMVs encode DNA-binding proteins ( Figure 5H ). These genes include hESC and lineage markers such as SOX2, POU5F1, ZIC3 (hESC); EOMES, T, GSC (ME); GLI3, SIX3, LHX3, PAX6 (NPC); GATA2, GATA6 (TBL); and RUNX1 (MSC). This list also includes transcription factor families that are located in clusters (such as HOX), as well as those that reside in different locations (such as FOX, ZIC, GATA, KLF, SIX, TBX, LHX, and DLX) . In addition, genes in DMVs are strongly enriched for those encoding components of development signaling pathways, including WNT, receptor tyrosine kinase (RTK), BMP, and Hedgehog ( Figure 5H ). Furthermore, there are 319 lncRNA genes with promoters that overlap with DMVs, including 22 lncRNA genes newly identified in this study ( Figure 5H and Table S7 ). Finally, we found 40 microRNA genes in DMVs ( Figure 5H and Table S7 ), 12 (30%) of which are known to be hESC specific (such as mir-302/367) (Suh et al., 2004) or within 10 kb of lineage-restricted genes that we identified (data not shown). Taken together, our data have revealed a unique class of genomic regions that show wide depletion of DNA methylation and are strongly associated with transcription factor genes and developmental genes.
The Majority of DMVs Remain Largely Unmethylated upon Cell Differentiation
Previously, bivalent genes marked by H3K4me3 and H3K27me3 were shown to be highly enriched for developmental genes (Bernstein et al., 2006) . Interestingly, DMV genes appear to be more enriched for transcription factors and developmental genes compared to bivalent genes in hESCs as defined in this study or previous studies (Pan et al., 2007; Zhao et al., 2007) (Figures 6A and S6A) . Additionally, genes in DMVs are not simply genes with long CGIs, high promoter CG density, or CGI clusters (Extended Experimental Procedures) (Figures 6A and S6B) . We then asked whether DMVs undergo dynamic epigenetic regulation upon H1 differentiation. We examined the DNA methylation levels in H1, the H1-derived cells, and a panel of published methylomes (see Figure 6D and its legend for the list) (Berman et al., 2012; Li et al., 2010; Lister et al., 2011) . Interestingly, most of the promoters in DMVs (89.5%, n = 968) remain hypomethylated in all cell types (Figures 6B and S6C) . The other 113 promoters demonstrate methylation level at or above 0.4 in at least one cell type ( Figures 6B and S6C) , including those at several HOX genes as shown previously (Bock et al., 2012; Laurent et al., 2010) , and genes that have low CG promoters include POU5F1 ( Figure 3E ), DPPA4 (data not shown), and the hESC-specific microRNA gene cluster mir-302/367 ( Figure 6C) . Notably, the expression of the mir-302/367 cluster can reprogram somatic cells to pluripotent cells (Anokye-Danso et al., 2011) . The activity of mir-302/367 may be regulated by DNA methylation as indicated by the hypermethylation of the associated DMV upon differentiation ( Figure 6C ). Therefore, a small subset of DMVs, including those at the HOX genes and a number of CG-poor promoters, shows dynamic DNA methylation during cell differentiation.
Next, we examined DMVs that remain hypomethylated upon cell differentiation. Among all 968 coding genes that are located in these DMVs, 259 are defined as aforementioned lineagerestricted genes. Most promoters of these genes are CG rich and are marked differentially by H3K27me3 in various lineages, while lacking DNA methylation in general ( Figure 6D ). Additionally, 134 genes are repressed in all six cell types and are also predominantly marked by H3K27me3, including HOXC5/C12/D3/ D4, FOXB2/D2/D4/E1, and PAX3/5/7 ( Figure 6D ). We then examined genes with DMVs that are expressed in most lineages (R4) in the current study, including those that are marked by H3K27me3 in at least one of the six cell types, and those that are not marked by H3K27me3 in any cell types ( Figure 6D ). The first group shows somewhat weak lineage-restricted expression. The second group is active in all six cell types. Gene ontology analysis shows that this group is not enriched for housekeeping genes but instead is still strongly enriched for transcription regulators, such as MYC, MLL, SRF, and CBX3, and several histone demethylase genes, KDM2A/2B, JARID2, and JMJD1C. Together, DMV genes appear to be largely marked by H3K4me3 and/or H3K27me3 ( Figures 6D and 6E) . Interestingly, this is also true in sperm as we examined data sets from published studies (Hammoud et al., 2009; Molaro et al., 2011) ( Figures 6D and 6E) . Consistent with the notion that many bivalent developmental genes become monovalent upon cell differentiation (Bernstein et al., 2006) , a larger portion of DMVs bear only either H3K4me3 or H3K27me3 in differentiated cells compared to that in sperm or H1 ( Figure 6E) . Interestingly, the sperm genome contains more DMVs than those in other cell types (n = 4,167), and most DMVs in H1 and the H1-derived cells (82.9%) are also present in sperm ( Figure 6F ). These observations are exemplified at two loci near HAND1 ( Figure 6G ) and MYC ( Figure 6H ). Therefore, we conclude that the majority of genes in DMVs remain hypomethylated upon H1 differentiation and are premarked by H3K27me3 and/or H3K4me3 in sperm.
Genes with DMVs Are Hypermethylated in Cancer As promoters with DMVs are preferentially hypomethylated in most cells that we examined, we sought to examine whether this is also true in cancer. Notably, DMV genes are enriched for genes involved in cancer pathways ( Figure 5H ), tumor suppressor genes (n = 120, p value = 2 3 10 À20 ) and oncogenes (n = 72, p value = 5 3 10 À14 ) (Cancer Gene Database, Memorial SloanKettering Cancer Center) (Table S7) . Interestingly, by examining base-resolution methylomes for normal and tumor colon tissues (Berman et al., 2012) , we found that promoters in DMVs gain significant levels of DNA methylation in the tumor tissue ( Figure 7A ). Genome wide, 54.0% of DMVs (n = 659) overlap with the ''methylation-prone elements'' in colon cancer (Berman et al., 2012) . Conversely, 28.9% of methylation-prone elements (n = 1,493) overlap with DMVs. Because the majority of methylation-prone elements (71%) are in nonpromoter regions (Berman et al., 2012) , but DMVs are present almost exclusively at promoters, we focused on the promoter regions for the following analysis. Strikingly, promoters that gain most DNA methylation in the tumor sample (DmCG/CG R 0.4) strongly overlap with DMVs identified in H1 and the H1-derived cells (Figures 7B and 7C) . This is true for promoters of both coding genes and lncRNA genes. Similar results were obtained using two additional hypermethylated gene lists in breast cancer and colorectal cancer ( Figure S7A ). As a control, promoters with DMVs remain hypomethylated in blood cells ( Figure 7B ). Importantly, most hypermethylated tumor suppressor genes in colon cancer are also DMV genes (16/22, p value = 1 3 10 À17 ). Unexpectedly, 12 oncogenes are also hypermethylated in colon cancer, among which 9 are DMV genes (p value = 2 3 10 À11 ). Previously, it was shown that many hypermethylated genes in cancer are Polycomb targets (Bracken and Helin, 2009) . Consistently, 87.2% (575/659) of hypermethylated DMVs, compared to 42% (236/ 561) of nonhypermethylated DMVs, are marked by K27me3 in H1. Taken together, these data suggest that, although DMV promoters are preferentially devoid of DNA methylation in normal cells, they are prone to hypermethylation in cancer.
DISCUSSION
It has long been recognized that epigenetic mechanisms play a critical role in mammalian development, but precisely how DNA methylation and chromatin modifications contribute to development has not yet been clearly elucidated. In this study, we focused on hESCs as a model and generated by far the most comprehensive reference epigenome maps of a multilineage differentiation system in humans. Importantly, we demonstrated that the majority of genes differentially expressed in early progenitors are CG rich and appear to employ H3K27me3-mediated repression in nonexpressing cells. Conversely, genes differentially expressed in later stages are largely CG poor and preferentially show DNA methylation-mediated gene silencing ( Figure 7D) . Surprisingly, we found more than 1,200 loci, termed DNA methylation valleys, that largely remain unmethylated in most cell types that we examined. , genes with longest CGIs (n = 1,081), genes with the highest promoter CG densities (n = 1,081), genes with CGI clusters (n = 1,019), hESC bivalent genes as defined in this study (n = 2,401) or in previous studies (Zhao et al., 2007 , n = 1,797 after gene symbol conversion; Pan et al., 2007, n = 3,301 after gene symbol conversion), all RefSeq genes, housekeeping genes (n = 3,140), and somatic-tissue-specific genes (n = 885) as defined in Zhu et al. (2008) . ( (legend continued on next page)
These regions are uniquely enriched for transcription factor and developmental regulatory genes. Interestingly, DMVs frequently gain abnormal DNA methylation in cancer, suggesting that alterations in DNA methylation machinery might be an important epigenetic mechanism aiding tumorigenesis. In accordance with an independent study of human ES cells differentiating to cells representative of three germ layers (Gifford et al., 2013 [this issue of Cell]), we observed cell-type-specific, dynamic DNA methylation and H3K27me3 at enhancers during ES cell differentiation. Our analysis further demonstrated that dynamic changes of DNA methylation and chromatin marks at enhancers correlate with gene expression, suggesting a potential role of epigenetic modulators in regulating enhancer activities.
Distinct Epigenetic Mechanisms at Lineage-Restricted Genes Expressed at Early and Late Stages of ES Cell Differentiation
Previous studies have shown that somatic-tissue-specific promoters tend to be CG poor (Barrera et al., 2008; Schug et al., 2005) . However, we found that a large number of CG-rich pro- moters appear to drive lineage-specific expression in hESC-derived early precursor cells. In line with previous studies, these CG-rich promoters tend to employ Polycomb, but not DNA methylation, for repression (Meissner et al., 2008; Mendenhall et al., 2010; Mohn et al., 2008) . By contrast, dynamic DNA methylation is frequently observed at the late-stage lineage-restricted promoters, which are characterized by CG-poor sequences. Similar results were obtained when we analyzed two published time course data sets for single lineage hESC differentiation to trophoblast (Xu et al., 2002) (Figure S7B ) or cardiovascular cells (Paige et al., 2012) ( Figure S7C ). Together, these data add to the notion that low and high CG promoters are regulated by distinct epigenetic regulatory mechanisms (Meissner et al., 2008) and further suggest a temporal relationship of DNA methylation and Polycomb in regulating cell-type-specific genes.
DMVs Are a Special Class of Genomic Loci Subject to Exquisite Epigenetic Control Interestingly, many genes encoding for key regulators of embryonic development reside in hypomethylated domains, or DMVs. Importantly, these DMVs are also preferentially hypomethylated in sperm, raising the possibility that these DMVs may be established even earlier. Why are developmental regulatory genes preferentially located in DMVs? One possibility is that DNA methylation at these regions may be incompatible with maintenance of the pluripotency or multipotency of these cells. We (D) Heatmaps showing RNA, H3K27ac, H3K4me3, H3K27me3, and DNA methylation levels for promoters of genes with DMVs within various categories. The levels of DNA methylation in additional 11 cell types and sperm, as well as the levels of H3K4me3 and H3K27me3 in sperm, are also shown. 1, hESC H9; 2-4, foreskin fibroblast (FF)-derived iPSC lines (19.11,6.9,19 .7); 5, adipose-derived stem (ADS) cell iPSCs; 6, FF iPSC-derived trophoblast-like cells; 7, ADS; 8, ADSderived adipocytes; 9, FF (Lister et al., 2011) ; 10, PMBC (blood) ; 11, colon tissue (Berman et al., 2012) . noticed that many DMV genes demonstrate a bivalent state (H3K4me3 and H3K27me3), which is linked to poised transcription that may enable developmental genes to be more flexibly modulated (Bernstein et al., 2006) . DNA methylation, on the other hand, may be required for more stable silencing of genes in terminally differentiated cells. Another possibility is that the genetic programs regulating embryonic development may actually evolve separately from, or prior to, the evolution of DNA methylation machinery. Supporting this hypothesis, DNA methylation is either absent (such as in Drosophila and C. elegans) or varies considerably in its pattern relative to gene activity in invertebrates (Feng et al., 2010; Zemach et al., 2010) . On the other hand, the Polycomb family of factors regulates key developmental regulatory genes in both invertebrates and vertebrates in a more conserved manner. Several mechanisms of DNA hypomethylation at DMVs can be envisioned. DMVs may be recognized by proteins, such as the Tet family, that actively remove DNA methylation (Wu and Zhang, 2011) . Alternatively, DMVs may be associated with histone modifications or histone variants, such as H3K4me3 or H2A.Z, that are incompatible to DNA methylation (Cedar and Bergman, 2009 ). Future experiments are needed to determine which of the above mechanisms could be responsible for DMV formation in the mammalian genome.
EXPERIMENTAL PROCEDURES
hESC Differentiation H1 cells were differentiated according to previously established protocols to mesendoderm (Yu et al., 2011) , trophoblast-like cells (Xu et al., 2002) , neural progenitor cells (Chambers et al., 2009; Chen et al., 2011) , and mesenchymal stem cells (Vodyanik et al., 2010) . Details of the differentiation methods can be found in Extended Experimental Procedures.
MethylC-Seq Library Generation and Sequencing
Genomic DNA from H1 and the H1-derived cells was extracted and sonicated. Sequencing libraries were constructed using NEBNext DNA Sample Prep Reagent Set 1 (NEB). Methylated adapters were used in place of the standard genomic DNA adapters from Illumina. Ligation products were purified, bisulfite treated, PCR amplified, and sequenced using HiSeq2000 (Illumina).
ChIP-Seq Library Generation and Sequencing H1 and the H1-derived cells were processed following a ChIP protocol as previously described (Hawkins et al., 2010) . ChIP libraries were prepared and sequenced using the Illumina instrument per manufacturer's instructions.
RNA-Seq Library Generation and Sequencing
Total RNA from H1 and the H1-derived cells was extracted and sequencing libraries were constructed using the TruSeq RNA Sample Prep Kit (Illumina) (Poly(A) selected) according to manufacturer's instructions with modifications to confer strand specificity (see Extended Experimental Procedures for details).
ACCESSION NUMBERS
All data have been deposited to the Sequence Read Archive (SRA) under accession number SRP000941.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven figures, and seven tables and can be found with this article online at http://dx. doi.org/10.1016/j.cell.2013.04.022.
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